DCPH News and Press, Deciphera Pharmaceuticals Inc. From 09/10/21

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the Company will host a virtual investor event to review the rebastinib and vimseltinib clinical data to be presented at the upcoming European Society for Medical Oncology (ESMO) Congress 2021 on Friday, September 17, 2...

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the 19 th Annual Morgan Stanley Global Healthcare Conference on September 9, 2021 at 2:45 PM ET. The conference will be he...

Image source: The Motley Fool. Deciphera Pharmaceuticals, inc (NASDAQ: DCPH) Q2 2021 Earnings Call Aug 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Deciphera Pharmaceuticals, inc (DCPH) Q2 2021 Earnings Call T...

Deciphera Pharmaceuticals, Inc. (DCPH) Q2 2021 Earnings Conference Call August 3, 2021 16:30 ET Company Participants Jen Robinson - Vice President, Investor Relations Steve Hoerter - President and Chief Executive Officer Dan Martin - Chief Commercial Officer Matt Sherman - Chief Medical Offic...

- Second Quarter 2021 QINLOCK® Net Product Revenue of $22.0 Million - - Top-line Results from INTRIGUE Phase 3 Study of QINLOCK in Patients with Second-line Gastrointestinal Stromal Tumor (GIST) Expected in the Fourth Quarter of 2021 - - First Patient Treated in P...

AFG, AIZ, AKAM, AMGN, APAM, ATVI, AYX, BKH, BLKB, BNFT, CAR, CDLX, COUR, CW, CZR, DCPH, DEI, DENN, DK, DVA, DVN, ET, EVTC, FICO, FMC, FNF, FRG, GBT, GDOT, H, HPP, HST, ICFI, ICHR, INFN, INSP, IOSP, JAZZ, KAI, KAR, KFRC, KTOS, KWR, LPSN, LSCC, LSI, LYFT, LYV, MANT, MGRC, MRCY, MTCH, MYGN, NBIX...

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that it will report its second quarter 2021 financial results on Tuesday, August 3, 2021. In connection with the earnings release, Deciphera’s management team will host a live conference call and webcast at 4:30 P...

Biotech stock investing is full of ups and downs. Anyone who's been watching ChemoCentryx (NASDAQ: CCXI) and Deciphera Pharmaceuticals (NASDAQ: DCPH) lately can tell you all about the downs. Shares of ChemoCentryx were soaring in 2020 until an FDA advisory committee vote...

janiecbros/E+ via Getty Images Biotech M&A is poised to heat up again as shares of the SPDR S&P Biotech’s (XBI) have fallen about 25% from their February highs, according to Jefferies. Biotech deals may pick up after a 3-6 month of a large "drawdown" and as prices "normalize" f...